Evotec SE (XSWX:EVT) E10: CHF-0.09 (As of Mar. 2026)


XSWX:EVT Evotec SE XSWX:EVT
68 GF Score
Price CHF4.50
GF Value CHF6.99
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Evotec SE E10?

Evotec SE XSWX:EVT +4.02% 68 E10 is CHF-0.09 as of Mar. 2026. GuruFocus rates XSWX:EVT with a GF Score™ of 68/100 and a GF Value™ of CHF6.99 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2026 was CHF-0.628. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF-0.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Evotec SE's average E10 Growth Rate was -433.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Evotec SE was 84.20% per year. The lowest was -41.50% per year. And the median was 12.30% per year.

As of today (2026-06-28), Evotec SE's current stock price is CHF4.50. Evotec SE's E10 for the quarter that ended in Mar. 2026 was CHF-0.09. Evotec SE's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Evotec SE was 592.25. The lowest was 55.53. And the median was 150.40.


Evotec SE  (XSWX:EVT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Evotec SE was 592.25. The lowest was 55.53. And the median was 150.40.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Evotec SE E10 Related Terms


Evotec SE E10 Historical Data

* Premium members only.

The historical data trend for Evotec SE's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE E10 Chart

Evotec SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.31 0.00 0.00 0.00

Evotec SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.09

XSWX:EVT vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's Shiller PE Ratio falls into.


XSWX:EVT
68GF Score
Evotec SE XSWX:EVT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evotec SE E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evotec SE's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.628/131.2583*131.2583
=-0.628

Current CPI (Mar. 2026) = 131.2583.

Evotec SE Quarterly Data

per share eps CPI Adj_EPS
201606 0.033 100.717 0.043
201609 0.076 101.017 0.099
201612 0.118 101.217 0.153
201703 0.054 101.417 0.070
201706 0.022 102.117 0.028
201709 0.023 102.717 0.029
201712 0.082 102.617 0.105
201803 0.023 102.917 0.029
201806 0.116 104.017 0.146
201809 0.260 104.718 0.326
201812 0.237 104.217 0.298
201903 0.102 104.217 0.128
201906 -0.022 105.718 -0.027
201909 0.142 106.018 0.176
201912 0.055 105.818 0.068
202003 0.117 105.718 0.145
202006 -0.075 106.618 -0.092
202009 -0.011 105.818 -0.014
202012 0.000 105.518 0.000
202103 0.354 107.518 0.432
202106 0.405 108.486 0.490
202109 0.890 109.435 1.067
202112 -0.208 110.384 -0.247
202203 -0.420 113.968 -0.484
202206 -0.164 115.760 -0.186
202209 -0.260 118.818 -0.287
202212 -0.148 119.345 -0.163
202303 -0.079 122.402 -0.085
202306 -0.078 123.140 -0.083
202309 -0.211 124.195 -0.223
202312 -0.086 123.773 -0.091
202403 -0.116 125.038 -0.122
202406 -0.520 125.882 -0.542
202409 -0.207 126.198 -0.215
202412 -0.215 127.041 -0.222
202503 -0.172 127.779 -0.177
202506 -0.225 128.412 -0.230
202509 -0.224 129.255 -0.227
202512 0.084 129.361 0.085
202603 -0.628 131.258 -0.628

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of CHF-0.09 mean?
Evotec SE (XSWX:EVT) has a E10 of CHF-0.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Evotec SE and its competitors.
Is Evotec SE's E10 too high?
Evotec SE's current E10 is CHF-0.09. Overall, Evotec SE has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evotec SE's E10 compare to ZTS and UTHR?
Evotec SE's E10 of CHF-0.09 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Evotec SE and its competitors. Evotec SE's current E10 is CHF-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evotec SE stock overvalued right now?
Based on GuruFocus' analysis, Evotec SE (XSWX:EVT) is currently considered Possible Value Trap. The stock's GF Value™ is CHF6.99, compared to a current price of CHF4.50 — trading 35.6% below its estimated fair value. The current E10 is CHF-0.09. Evotec SE's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Evotec SE (XSWX:EVT), the current E10 is CHF-0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evotec SE (XSWX:EVT) Overvalued in 2026?

Based on GuruFocus' analysis, Evotec SE stock appears to be undervalued. The current stock price of CHF4.50 is trading 35.6% below its estimated GF Value™ of CHF6.99. GuruFocus considers Evotec SE to be Possible Value Trap.

Key valuation signals for XSWX:EVT:

  • E10: CHF-0.09
  • GF Value™: CHF6.99 vs. price of CHF4.50 (35.6% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XSWX:EVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evotec SE Business Description

Address Essener Bogen 7, 22419 Hamburg, Hamburg, DEU, 22419
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
68GF Score

Get the complete analysis for XSWX:EVT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF4.50
Price
CHF6.99
GF Value